Critical-illness-Polyneuropathie
und -Myopathie

W Müllges; G Stoll

doi:10.1055/s-0031-1275805

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2011; 136(15): 769-774
DOI: 10.1055/s-0031-1275805

Aktuelle Diagnostik & Therapie | Review article

Intensivmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Critical-illness-Polyneuropathie und -Myopathie

Critical illness polyneuropathy and myopathyW. Müllges¹ , G. Stoll¹

¹Neurologische Klinik, Universitätsklinikum Würzburg

Abstract

Schlüsselwörter

critical-illness-Polyneuropathie - critical-illness-Myopathie

Keywords

critical illness polyneuropathy - critical illness myopathy

Full Text

References

Literatur

1 Bednarik J, Vondracek P, Dusek L. et al . Risk factors for critical illness polyneuromyopathy. J Neurol. 2005; 252 343-351
2 Bolton C F, Gilbert J J, Hahn A F, Sibbald W F. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984; 47 1223-1231
3 Bolton C F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996; 24 1408-1416
4 deJonghe B, Sharshar T, Lefaucher J P. et al . Paresis aquired in the intensive care unit: a prospective multicenter study. JAMA. 2002; 288 2859-2867
5 deLetter M A, Schmitz P I, Visser L H. et al . Risk factors fort he development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001; 29 2281-2286
6 Druschky A, Herkert M, Radespiel-Troger M. et al . Critical illness-polyneuropathy: clinical findings and cell culture assay of neurotoxicity by a prospective study. Intensive Care Med. 2001; 27 686-693
7 Esteban A, Frutos F, Tobin M J. et al . A comparison of four methods of weaning patients from mechanical ventilation. New Engl J Med. 1995; 332 345-50
8 Feasby T, Banwell B, Benstead T. et al . Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev. 2007; 21 (Suppl 1) S57-S107
9 Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia J L. et al . Critical illness-Polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001; 27 1288-1296
10 Garnacho-Montero J, Amaya-Villar R Garcia-Garmendia JL. et al . Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay of septic patients. Crit Care Med. 2005; 33 349-354
11 Guaneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicenter CRIMYNE study. J Neurol Neurosurg Psychiatry. 2008; 79 838-841
12 Hermanns G, Vanhorebeck I, Derde S, vanden B erghe G. Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med. 2009; 9 (suppl) S391-397
13 Herridge M S, Cheung A M, Tansey C M. et al . One year outcomes in survivors of the acute respiratory distress syndrome. Engl J Med. 2003; 348 683-693
14 Heyland D K, Dhaliwal R, Suchner U. et al . Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005; 31 327-337
15 Hund E. Myopathy in critically ill patients. Crit Care Med. 1999; 27 2544-2547
16 Intiso D, Amoruso L, Zarelli M. et al . Long-term functional outcome and health status of patients with critical illness polyneuromyopathy. Acta Neurol Scand. 2010; Aug 19 [epub ahead of print];
17 Khan J, Harrison T B, Rich M M. et al . Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006; 67 1421-1425
18 Latronico N, Fenzi F, Recupero D. et al . Critical illness myopathy and neuropathy. Lancet. 1996; 347 1579-1582
19 Latronico N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both?. Intensive Care Med. 2003; 29 1411-13
20 Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005; 11 126-132
21 Latronico N, Bertolini G, Guarneri B. et al . Simplified electrophysiological evaluation of peripheral nerves in critically ill patients. The CRIMYNE study. Crit Care. 2007; 11 (1) R11
22 Lefaucheur J P, Nordine P, Rodriguez P. et al . Origin of ICU aquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatr. 2006; 77 500-506
23 Levine S, Nguyen T, Taylor N. et al . Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. New Engl J Med. 2008; 358 1327-1335
24 Marik P E, Zaloga G P. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008; 34 1980-1990
25 Massa R, Carpenter S, Holland P. et al . Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve. 1992; 15 1290-1298
26 Mertens H G. Disseminierte Polyneuropathie nach Koma. Nervenarzt. 1961; 32 71-79
27 Mohr M, Englisch L, Roth A. et al . Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med. 1997; 23 1144-1149
28 Müllges W, Stoll G. Intensivmedizinische Behandlung neuromuskulärer Krankheiten. Intensivmedizin up-2-date. 2009; 5 209-28
29 Müllges W, Stoll G. Akuttherapie des Guillain-Berré-Syndroms und der myasthenen Krise. Erkrankungen. Akt Neurol. 2010; 37 474-484
30 Needham D M. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA. 2008; 300 1685-1690
31 Reinhart K, Brunkhorst F M, Bone H G. et al .Prävention, Therapie und Nachsorge der Sepsis. S2k-Leitlinie der Deutschen Sepsis-Gesellschaft und Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin. 2010 www.awmf.org
32 Steinberg K P, Hudson L D, Goodman R B. et al . Efficiacy and safety of corticosteroids for persistent acute respiratory distress syndrome. New Engl J Med. 2006; 354 1671-1684
33 Tennila A, Salmi T, Pettila V. et al . Early signs of critical illness polyneuropathy in ICU patients. Intensive Care Med. 2000; 26 1360-1363
34 Tjader I, Rooyackers O, Forsberg A M. et al . Effects on skeletal muscle of intravenous glutamine supplementation in ICU patients. Intensive Care Med. 2004; 30 266-275
35 van den Berghe C, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients. New Engl J Med. 2001; 345 1359-1367
36 van den Berghe C, Schoenheyt K, Becx P. et al . Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005; 64 1348-1353
37 Williams S, Horrocks I, Ouvrier R A. et al . Critical illness polyneuropathy and myopathy in pediatric intensive care: a review. Pediatric Crit Care Med. 2007; 8 18-22
38 Zifko U A, Zipko H T, Bolton C F. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci. 1998; 159 186-193
39 Zochodne D W, Bolton C F, Wells G A. et al . Critical illness polyneuropathy. Brain. 1987; 110 619-642

Priv.-Doz. Dr. Wolfgang Müllges

Neurologische Klinik, Universitätsklinikum Würzburg

Josef Schneider Str.11

97080 Würzburg

Phone: 0931/201-23764

Fax: 0931/201-61796

Email: Muellges_w@klinik.uni-wuerzburg.de